Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NICE data highlight hypertension management needs:

This article was originally published in Clinica

Executive Summary

Updated guidance on the management of hypertension, issued by the UK's National Institute for Health and Clinical Excellence (NICE) today (June 28), focuses on the pharmacological treatment of the condition, adding nothing new to current policy on diagnosis and monitoring. However, data on the UK's incidence of the condition reveal that around 40% of the adult population are hypertensive - the proportion rises with age - and that inadequate management of the condition is the single greatest risk factor in stroke, coronary heart disease and chronic renal failure.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052130

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel